<DOC>
	<DOCNO>NCT00564538</DOCNO>
	<brief_summary>The purpose study compare kidney function , long term patient graft survival , incidence acute rejection liver transplant recipients one group receive thymoglobulin induction delay initiation tacrolimus another group liver transplant recipient immediate administration tacrolimus without induction immunosuppression .</brief_summary>
	<brief_title>A Study Thymoglobulin Tacrolimus Liver Transplant</brief_title>
	<detailed_description>Renal insufficiency follow liver transplantation adult recipient major cause morbidity major contributor mortality . One key factor contribute renal dysfunction use calcineurin inhibitor . There evidence suggest first 7-10 day follow liver transplantation crucial term renal function ability avoid use nephrotoxic agent calcineurin inhibitor may significant impact long-term outcome .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<criteria>Primary liver transplant recipient Model End Stage Liver Disease ( MELD ) criterion documentation Over 18 year age Signed informed consent form female childbearing potential : Must lactating Must negative serum pregnancy test study day 0 Must agree reliable acceptable form contraception study sexually active male must practice acceptable form contraception Multiple organ transplant Prior solid organ bone marrow transplant recipient Fulminant hepatic failure Status 1 transplant Liver transplant candidate great 6 week dialysis Patients opinion Investigator eligible thymo induction time transplant Recipients investigational therapy within 90 day prior transplant Know contraindication administration rabbit antithymocyte globulin Patients whose medical condition physician feel would best interest participate study Patients unwilling Glofil nuclear medicine scan specify time point History malignancy within 5 year exception : Adequately treat localized squamous basal cell carcinoma skin without evidence recurrence , /or Hepatocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>liver transplant</keyword>
</DOC>